#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Kearns-Sayre syndrome Conjunctivitis allergic Familial amyotrophic lateral sclerosis Oesophageal adenocarcinoma Exudative retinopathy Oropharyngeal squamous cell carcinoma Chronic myeloid leukaemia Proteus syndrome Cutaneous T-cell lymphoma recurrent Cerebral amyloid angiopathy Graft versus host disease Arrhythmogenic right ventricular dysplasia SAPHO syndrome Medulloblastoma More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent Hereditary hypophosphataemic rickets – Trials in Disease Lymphangioma – Treatment Soft tissue sarcoma – Life with Disease Fragile X syndrome – Trials in Disease Usher’s syndrome – Life with Disease Congenital generalised lipodystrophy – Life with Disease Waldenstrom’s macroglobulinaemia Systemic sclerosis pulmonary Mantle cell lymphoma refractory – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Degarelix AZD5335 Pregabalin Prs-344 Danicamtiv Other Blood Products Ritonavir Pimozide Lactulose Zoledronic Acid Vb10.16 LY3537021 BGB-16673 Raltegravir Purified Egg Phospholipids Amlitelimab SGN-ALPV [18F] CANAGLIFLOZIN Tecovirimat Enzalutamide More therapies…

    Learn about Your Condition

    Biliary tract disorder Colorectal cancer stage IV Deafness traumatic Glomerulonephritis acute Bacteraemia Yellow fever Mite allergy Anxiety Substance use disorder Adrenoleukodystrophy Retinal vein occlusion Hyperkalaemia Portal hypertension Pleomorphic leiomyosarcoma Congenital myopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of ficerafusp alfa and nivolumab in patients with head and neck cancer who did not respond to platinum-based chemotherapy.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Nivolumab
    France

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +19

  • Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    Investigated Drugs:
    • Chlorhexidine Gluconate
    • Metronidazole
    Germany

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Finland

  • Standardization of Olea europaea pollen extract for patients with olive pollen allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Olea Europaea Pollen Extract
    • Sodium Chloride
    Spain

  • Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Elranatamab
    • Teclistamab
    Sweden
Previous Page
1 … 51 52 53 54 55 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!